Synthesis and self-assembly properties of a novel [poly(ethylene glycol)]-fluorocarbon-phospholipid triblock copolymer

Tetrahedron Letters

Volumn 48, Issue 22, 2007, Pages 3879-3882

  Slaughter, Jennifer N ^a   Schmidt, Karen M ^a   Byram, Julee L ^a   Mecozzi, Sandro ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

[POLY (ETHYLENE GLYCOL)] FLUOROCARBON PHOSPHOLIPID TRIBLOCK COPOLYMER; COPOLYMER; PHOSPHOLIPID DERIVATIVE; PYRENE; UNCLASSIFIED DRUG;

ARTICLE; CONJUGATION; FLUORESCENCE ANALYSIS; LIGHT SCATTERING; MICELLIZATION; SYNTHESIS;

EID: 34247616771     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2007.03.148     Document Type: Article

References (23)

1. Torchilin V.P. CMLS 61 (2004) 2549-2559
2. Strickley R.G. Pharm. Res. 21 (2004) 201-230
3. Torchilin V.P. J. Controlled Release 73 (2001) 137-172
4. Lavasanifar A., Samuel J., and Kwon G. Adv. Drug Delivery Rev. 54 (2002) 169-190
5. Lukyanov A.N., and Torchilin V.P. Adv. Drug Delivery Rev. 56 (2004) 1273-1289
6. Krafft M.P. In: Gladysz J.A., Curran D.P., and Horvath I.T. (Eds). Handbook of Fluorous Chemistry (2004), Wiley-VCH, Weinheim Chapter 12
7. Kissa E. Fluorinated Surfactants and Repellents. 2nd ed. Surfactant Science Series Vol. 97 (2001), Marcel Dekker, New York
8. Riess J.G. Tetrahedron 58 (2002) 4113-4131
9. Krafft M.P. Adv. Drug Delivery Rev. 47 (2001) 209-228
10. Vierling P., Santaella C., and Greiner J. J. Fluorine Chem. 107 (2001) 337-354
11. Hoang K.C., and Mecozzi S. Langmuir 20 (2004) 7347-7350
12. Harris J.M., and Chess R.B. Nat. Rev. Drug Discovery 2 (2003) 214-221
13. Gabizon A., Barenholz Y., and Bialer M. Pharm. Res. 10 (1993) 703-708
14. van Etten E.W.M., van Vianen W., Tijhuis R., Storm G., and Bakker-Woudenberg I. J. Controlled Release 37 (1995) 123-129
15. Kwon G.S., Kuldipkumar A., Tan Y., and Andes D. PMSE Prepr. 89 (2003) 50-51
16. Krishnadas A., Rubinstein I., and Onyuksel H. Pharm. Res. 20 (2003) 297-302
17. Ashok B., Arleth L., Hjelm R.P., Rubinstein I., and Onyuksel H. J. Pharm. Sci. 93 (2004) 2476-2487
18. Preparation and characterization of compounds 1-6 are available as Supplementry data.
19. Zalipsky S. Bioconjugate Chem. 4 (1993) 296-299
20. The samples for DLS studies were prepared by dissolving 1 in dichloromethane and subsequently concentrating the solution in vacuo to give a thin film. This was reconstituted in water so that the concentration of the solution was 1.25 mg/mL. The solution was then sonicated for 15 min and allowed to equilibrate for 30 min. The solution was passed through a 0.20 mm filter directly into a quartz cuvette used for the measurements. The data were collected and analyzed in triplicate.
21. Kalyanasundaram K., and Thomas J.K. J. Am. Chem. Soc. 99 (1977) 2039-2044
22. Dong D.C., and Winnik M.A. Can. J. Chem. 62 (1984) 2560-2565
23. The samples for CMC determination were prepared by first transferring a solution of pyrene in acetone (12 mL of a 100 mM solution) to clean, dry 2 dram vials. The acetone was removed in vacuo and solutions of polymer in water were added so that the final pyrene concentration was 0.5 mM. The vials were then heated to 70 °C with good stirring in an oil bath for 1.5 h, and then allowed to equilibrate at room temperature for 2 h with no stirring. The solutions were transferred directly to a clean, dry cuvette used for the measurements. Data for each concentration were obtained in triplicate, and the reported values are the average of these measurements.